The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Dirk Rades

Department of Radiation Oncology

University of Lubeck

Lubeck

Germany

[email]@gmx.net

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Radiation Oncology, University of Lubeck, Lubeck, Germany. 2000 - 2012
  • University of Lubeck, Lubeck, Germany. 2010

References

  1. A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer. Rades, D., Douglas, S., Veninga, T., Schild, S.E. BMC. Cancer (2012) [Pubmed]
  2. Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis. Rades, D., Panzner, A., Dziggel, L., Haatanen, T., Lohynska, R., Schild, S.E. Cancer (2012) [Pubmed]
  3. Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis. Rades, D., Kueter, J.D., Gliemroth, J., Veninga, T., Pluemer, A., Schild, S.E. Strahlenther. Onkol (2012) [Pubmed]
  4. Cisplatin superior to carboplatin in adjuvant radiochemotherapy for locally advanced cancers of the oropharynx and oral cavity. Rades, D., Ulbricht, T., Hakim, S.G., Schild, S.E. Strahlenther. Onkol (2012) [Pubmed]
  5. Single brain metastasis: Radiosurgery alone compared with radiosurgery plus up-front whole-brain radiotherapy. Rades, D., Hornung, D., Veninga, T., Schild, S.E., Gliemroth, J. Cancer (2012) [Pubmed]
  6. The prognostic impact of tumor cell expression of estrogen receptor-α, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer. Rades, D., Setter, C., Dahl, O., Schild, S.E., Noack, F. Cancer (2012) [Pubmed]
  7. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer. Rades, D., Setter, C., Dahl, O., Schild, S.E., Noack, F. Int. J. Radiat. Oncol. Biol. Phys. (2012) [Pubmed]
  8. Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection. Rades, D., Veninga, T., Hornung, D., Wittkugel, O., Schild, S.E., Gliemroth, J. Cancer (2012) [Pubmed]
  9. Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): a matched pair analysis. Rades, D., Kronemann, S., Meyners, T., Schild, S.E., Hakim, S.G. Oral Oncol. (2010) [Pubmed]
  10. Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC). Rades, D., Setter, C., Dunst, J., Dahl, O., Schild, S.E., Noack, F. Strahlenther. Onkol (2010) [Pubmed]
  11. Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. Rades, D., Huttenlocher, S., Dunst, J., Bajrovic, A., Karstens, J.H., Rudat, V., Schild, S.E. J. Clin. Oncol. (2010) [Pubmed]
  12. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma. Rades, D., Heisterkamp, C., Huttenlocher, S., Bohlen, G., Dunst, J., Haatanen, T., Schild, S.E. Int. J. Radiat. Oncol. Biol. Phys. (2010) [Pubmed]
  13. The role of postoperative radiotherapy for the treatment of gangliogliomas. Rades, D., Zwick, L., Leppert, J., Bonsanto, M.M., Tronnier, V., Dunst, J., Schild, S.E. Cancer (2010) [Pubmed]
  14. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder. Rades, D., Meyners, T., Veninga, T., Stalpers, L.J., Schild, S.E. Int. J. Radiat. Oncol. Biol. Phys. (2010) [Pubmed]
  15. Treatment of painful bone metastases. Rades, D., Schild, S.E., Abrahm, J.L. Nat. Rev. Clin. Oncol (2010) [Pubmed]
  16. Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: results of a matched pair analysis. Rades, D., Kueter, J.D., Veninga, T., Gliemroth, J., Schild, S.E. Eur. J. Cancer (2009) [Pubmed]
  17. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases. Rades, D., Kueter, J.D., Pluemer, A., Veninga, T., Schild, S.E. Int. J. Radiat. Oncol. Biol. Phys. (2009) [Pubmed]
  18. Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer. Rades, D., Fischer, D., Veninga, T., Stalpers, L.J., Schild, S.E. Gynecol. Oncol. (2009) [Pubmed]
  19. Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy. Rades, D., Golke, H., Schild, S.E., Kilic, E. Strahlenther. Onkol (2008) [Pubmed]
  20. Cisplatin alone or in combination versus hydroxyurea during pelvic irradiation for cervical cancer. Rades, D., Schild, S.E. Nat. Clin. Pract. Oncol (2008) [Pubmed]
  21. Comparison of different treatment approaches for one to two brain metastases in elderly patients. Rades, D., Pluemer, A., Veninga, T., Schild, S.E. Strahlenther. Onkol (2008) [Pubmed]
  22. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases. Rades, D., Kueter, J.D., Hornung, D., Veninga, T., Hanssens, P., Schild, S.E., Dunst, J. Strahlenther. Onkol (2008) [Pubmed]
  23. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer. Rades, D., Stoehr, M., Meyners, T., Bohlen, G., Nadrowitz, R., Dunst, J., Schild, S.E., Wroblewski, J., Albers, D., Schmidt, R., Alberti, W., Tribius, S. Strahlenther. Onkol (2008) [Pubmed]
  24. Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis. Rades, D., Kieckebusch, S., Haatanen, T., Lohynska, R., Dunst, J., Schild, S.E. Int. J. Radiat. Oncol. Biol. Phys. (2008) [Pubmed]
  25. The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation. Rades, D., Golke, H., Schild, S.E., Kilic, E. Int. J. Radiat. Oncol. Biol. Phys. (2008) [Pubmed]
  26. Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression. Rades, D., Rudat, V., Veninga, T., Stalpers, L.J., Hoskin, P.J., Schild, S.E. Cancer (2008) [Pubmed]
  27. Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy. Rades, D., Stoehr, M., Kazic, N., Hakim, S.G., Walz, A., Schild, S.E., Dunst, J. Int. J. Radiat. Oncol. Biol. Phys. (2008) [Pubmed]
  28. Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer. Rades, D., Fehlauer, F., Sheikh-Sarraf, M., Kazic, N., Basic, H., Poorter, R., Hakim, S.G., Schild, S.E., Dunst, J. Head. Neck (2008) [Pubmed]
  29. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Rades, D., Dunst, J., Schild, S.E. Strahlenther. Onkol (2008) [Pubmed]
  30. Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer. Rades, D., Setter, C., Schild, S.E., Dunst, J. Int. J. Radiat. Oncol. Biol. Phys. (2008) [Pubmed]
  31. Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin. Rades, D., Kuhn, H., Schultze, J., Homann, N., Brandenburg, B., Schulte, R., Krull, A., Schild, S.E., Dunst, J. Int. J. Radiat. Oncol. Biol. Phys. (2008) [Pubmed]
  32. The first score predicting overall survival in patients with metastatic spinal cord compression. Rades, D., Dunst, J., Schild, S.E. Cancer (2008) [Pubmed]
  33. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Rades, D., Bohlen, G., Dunst, J., Lohynska, R., Veninga, T., Stalpers, L., Schild, S.E., Dahm-Daphi, J. Strahlenther. Onkol (2008) [Pubmed]
  34. A comparison of chemotherapy plus surgery with surgery alone for localized esophageal cancer. Rades, D., Schild, S.E. Nature Clinical Practice. Oncology (2008) [Pubmed]
  35. Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases. Rades, D., Veninga, T., Stalpers, L.J., Basic, H., Rudat, V., Karstens, J.H., Dunst, J., Schild, S.E. J. Clin. Oncol. (2007) [Pubmed]
  36. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Rades, D., Pluemer, A., Veninga, T., Dunst, J., Schild, S.E. Cancer (2007) [Pubmed]
  37. Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer. Rades, D., Schwarz, R., Todorovic, M., Thurmann, H., Graefen, M., Walz, J., Schild, S.E., Dunst, J., Alberti, W. Strahlenther. Onkol (2007) [Pubmed]
  38. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. Rades, D., Fehlauer, F., Wroblesky, J., Albers, D., Schild, S.E., Schmidt, R. Oral Oncol. (2007) [Pubmed]
  39. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases. Rades, D., Haatanen, T., Schild, S.E., Dunst, J. Cancer (2007) [Pubmed]
  40. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients. Rades, D., Schild, S.E., Lohynska, R., Veninga, T., Stalpers, L.J., Dunst, J. Cancer (2007) [Pubmed]
  41. High accuracy of virtual simulation with the laser system Dorado CT4. Rades, D., Frenzel, T., Schwarz, R., Walz, J., Cremers, F., Albers, D., Alberti, W., Schmidt, R. Strahlenther. Onkol (2007) [Pubmed]
  42. Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone? Rades, D., Walz, J., Schild, S.E., Veninga, T., Dunst, J. Urology (2007) [Pubmed]
  43. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Rades, D., Pluemer, A., Veninga, T., Hanssens, P., Dunst, J., Schild, S.E. Cancer (2007) [Pubmed]
  44. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Rades, D., Bohlen, G., Pluemer, A., Veninga, T., Hanssens, P., Dunst, J., Schild, S.E. Cancer (2007) [Pubmed]
  45. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary. Rades, D., Fehlauer, F., Veninga, T., Stalpers, L.J., Basic, H., Hoskin, P.J., Rudat, V., Karstens, J.H., Schild, S.E., Dunst, J. Int. J. Radiat. Oncol. Biol. Phys. (2007) [Pubmed]
  46. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression. Rades, D., Karstens, J.H., Hoskin, P.J., Rudat, V., Veninga, T., Schild, S.E., Dunst, J. Int. J. Radiat. Oncol. Biol. Phys. (2007) [Pubmed]
  47. Radiotherapy of metastatic spinal cord compression in very elderly patients. Rades, D., Hoskin, P.J., Karstens, J.H., Rudat, V., Veninga, T., Stalpers, L.J., Schild, S.E., Dunst, J. Int. J. Radiat. Oncol. Biol. Phys. (2007) [Pubmed]
  48. Radiotherapy is effective for metastatic spinal cord compression in patients with epithelial ovarian cancer. Rades, D., Schild, S.E., Dunst, J. Int. J. Gynecol. Cancer (2007) [Pubmed]
  49. Is stereotactic radiosurgery the best treatment option for patients with spinal metastases?. Rades, D., Schild, S.E. Nature Clinical Practice. Oncology (2007) [Pubmed]
  50. Is surgery necessary following chemoradiation for patients with locally advanced cancer of the esophagus?. Rades, D., Schild, S.E. Nature Clinical Practice. Oncology (2007) [Pubmed]
  51. Reduction of overall treatment time in patients irradiated for more than three brain metastases. Rades, D., Kieckebusch, S., Lohynska, R., Veninga, T., Stalpers, L.J., Dunst, J., Schild, S.E. Int. J. Radiat. Oncol. Biol. Phys. (2007) [Pubmed]
  52. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. Rades, D., Lohynska, R., Veninga, T., Stalpers, L.J., Schild, S.E. Cancer (2007) [Pubmed]
  53. Dose-response relationship for fractionated irradiation in the treatment of spinal meningeal melanocytomas: a review of the literature. Rades, D., Schild, S.E. J. Neurooncol. (2006) [Pubmed]
  54. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. Rades, D., Fehlauer, F., Schulte, R., Veninga, T., Stalpers, L.J., Basic, H., Bajrovic, A., Hoskin, P.J., Tribius, S., Wildfang, I., Rudat, V., Engenhart-Cabilic, R., Karstens, J.H., Alberti, W., Dunst, J., Schild, S.E. J. Clin. Oncol. (2006) [Pubmed]
  55. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. Rades, D., Veninga, T., Stalpers, L.J., Schulte, R., Hoskin, P.J., Poortmans, P., Schild, S.E., Rudat, V. Int. J. Radiat. Oncol. Biol. Phys. (2006) [Pubmed]
  56. Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer. Rades, D., Stalpers, L.J., Veninga, T., Rudat, V., Schulte, R., Hoskin, P.J. J. Urol. (2006) [Pubmed]
  57. Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas. Rades, D., Schild, S.E. Cancer (2006) [Pubmed]
  58. Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. Rades, D., Hoskin, P.J., Stalpers, L.J., Schulte, R., Poortmans, P., Veninga, T., Dahm-Daphi, J., Obralic, N., Wildfang, I., Bahrehmand, R., Engenhart-Cabilic, R., Schild, S.E. Int. J. Radiat. Oncol. Biol. Phys. (2006) [Pubmed]
  59. Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study. Rades, D., Walz, J., Stalpers, L.J., Veninga, T., Schulte, R., Obralic, N., Wildfang, I., Engenhart-Cabilic, R., Hoskin, P.J., Schild, S.E. Eur. Urol. (2006) [Pubmed]
  60. Prognostic value of haemoglobin levels during concurrent radio-chemotherapy in the treatment of oesophageal cancer. Rades, D., Lang, S., Schild, S.E., Alberti, W. Clin. Oncol. (R. Coll. Radiol) (2006) [Pubmed]
  61. Treatment recommendations for the various subgroups of neurocytomas. Rades, D., Schild, S.E. J. Neurooncol. (2006) [Pubmed]
  62. Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients. Rades, D., Stalpers, L.J., Schulte, R., Veninga, T., Basic, H., Engenhart-Cabilic, R., Schild, S.E., Hoskin, P.J. Eur. J. Cancer (2006) [Pubmed]
  63. Is 50 Gy sufficient to achieve long-term local control after incomplete resection of typical neurocytomas?. Rades, D., Schild, S.E. Strahlenther. Onkol (2006) [Pubmed]
  64. Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients?. Rades, D., Dahm-Daphi, J., Rudat, V., Schulte, R., Stalpers, L.J., Veninga, T., Hoskin, P.J. Strahlenther. Onkol (2006) [Pubmed]
  65. Well-differentiated neurocytoma: what is the best available treatment?. Rades, D., Fehlauer, F., Lamszus, K., Schild, S.E., Hagel, C., Westphal, M., Alberti, W. Neuro-oncology (2005) [Pubmed]
  66. Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels. Rades, D., Schild, S.E., Bahrehmand, R., Zschenker, O., Alberti, W.A., Rudat, V.R. Cancer (2005) [Pubmed]
  67. Epoetin-alpha during radiotherapy for stage III esophageal carcinoma. Rades, D., Schild, S.E., Yekebas, E.F., Job, H., Schwarz, R., Rudat, V. Cancer (2005) [Pubmed]
  68. Effectiveness and toxicity of single-fraction radiotherapy with 1 x 8 Gy for metastatic spinal cord compression. Rades, D., Stalpers, L.J., Hulshof, M.C., Zschenker, O., Alberti, W., Koning, C.C. Radiother. Oncol (2005) [Pubmed]
  69. Comparison of 1 x 8 Gy and 10 x 3 Gy for functional outcome in patients with metastatic spinal cord compression. Rades, D., Stalpers, L.J., Hulshof, M.C., Borgmann, K., Karstens, J.H., Koning, C.C., Alberti, W. Int. J. Radiat. Oncol. Biol. Phys. (2005) [Pubmed]
  70. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. Rades, D., Stalpers, L.J., Veninga, T., Schulte, R., Hoskin, P.J., Obralic, N., Bajrovic, A., Rudat, V., Schwarz, R., Hulshof, M.C., Poortmans, P., Schild, S.E. J. Clin. Oncol. (2005) [Pubmed]
  71. Spinal reirradiation after short-course RT for metastatic spinal cord compression. Rades, D., Stalpers, L.J., Veninga, T., Hoskin, P.J. Int. J. Radiat. Oncol. Biol. Phys. (2005) [Pubmed]
  72. Treatment of atypical neurocytomas. Rades, D., Fehlauer, F., Schild, S.E. Cancer (2004) [Pubmed]
  73. Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site. Rades, D., Raabe, A., Bajrovic, A., Alberti, W. Strahlenther. Onkol (2004) [Pubmed]
  74. Prognostic value of the MIB-1 labeling index for central neurocytomas. Rades, D., Schild, S.E., Fehlauer, F. Neurology (2004) [Pubmed]
  75. Therapy of meningeal melanocytomas. Rades, D., Schild, S.E., Tatagiba, M., Molina, H.A., Alberti, W. Cancer (2004) [Pubmed]
  76. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study. Rades, D., Fehlauer, F., Stalpers, L.J., Wildfang, I., Zschenker, O., Schild, S.E., Schmoll, H.J., Karstens, J.H., Alberti, W. Cancer (2004) [Pubmed]
  77. Defining the best available treatment for neurocytomas in children. Rades, D., Schild, S.E., Fehlauer, F. Cancer (2004) [Pubmed]
  78. Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma?. Rades, D., Bajrovic, A., Alberti, W., Rudat, V. Int. J. Radiat. Oncol. Biol. Phys. (2003) [Pubmed]
  79. Defining the optimal dose of radiation after incomplete resection of central neurocytomas. Rades, D., Schild, S.E., Ikezaki, K., Fehlauer, F. Int. J. Radiat. Oncol. Biol. Phys. (2003) [Pubmed]
  80. Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression. Rades, D., Heidenreich, F., Karstens, J.H. Int. J. Radiat. Oncol. Biol. Phys. (2002) [Pubmed]
  81. A comparison of two different radiation schedules for metastatic spinal cord compression considering a new prognostic factor. Rades, D., Karstens, J.H. Strahlenther. Onkol (2002) [Pubmed]
  82. Treatment options for central neurocytoma. Rades, D., Fehlauer, F. Neurology (2002) [Pubmed]
  83. Role of radiotherapy in the treatment of motor dysfunction due to metastatic spinal cord compression: comparison of three different fractionation schedules. Rades, D., Karstens, J.H., Alberti, W. Int. J. Radiat. Oncol. Biol. Phys. (2002) [Pubmed]
  84. Time of developing motor deficits before radiotherapy as a new and relevant prognostic factor in metastatic spinal cord compression: final results of a retrospective analysis. Rades, D., Heidenreich, F., Bremer, M., Karstens, J.H. Eur. Neurol. (2001) [Pubmed]
  85. Therapeutic options for meningeal melanocytoma. Case report. Rades, D., Heidenreich, F., Tatagiba, M., Brandis, A., Karstens, J.H. J. Neurosurg. (2001) [Pubmed]
  86. Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. Rades, D., Kühnel, G., Wildfang, I., Börner, A.R., Schmoll, H.J., Knapp, W. Ann. Oncol. (2001) [Pubmed]
  87. Prognostic significance of the time of developing motor deficits before radiation therapy in metastatic spinal cord compression: one-year results of a prospective trial. Rades, D., Blach, M., Bremer, M., Wildfang, I., Karstens, J.H., Heidenreich, F. Int. J. Radiat. Oncol. Biol. Phys. (2000) [Pubmed]
 
WikiGenes - Universities